Current topics in breast cancer clinical research, 2007 Noriaki Ohuchi Introduction to Review Articles 29 February 2008 Pages: 1 - 2
Update of evidence in chemotherapy for breast cancer Hiroyasu YamashiroMasakazu Toi Review Article 29 February 2008 Pages: 3 - 7
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan Toshiaki SaekiMuneo SanoShigemitsu Takashima Review Article 29 February 2008 Pages: 8 - 11
Significance of irradiation in breast-conserving treatment: comparison of local recurrence rates in irradiated and nonirradiated groups Takanori IshidaMotohiro TakedaNoriaki Ohuchi Review Article 29 February 2008 Pages: 12 - 17
Treatment of breast cancer with bone metastasis: bisphosphonate treatment — current and future Norio Kohno Review Article 29 February 2008 Pages: 18 - 23
Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy Noriaki WadaShigeru Imoto Review Article 29 February 2008 Pages: 24 - 32
Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update Kazuyuki IshiharaToshiaki SaidaThe Prognosis and Statistical Investigation Committee of the Japanese Skin Cancer Society Cancer Statistics 29 February 2008 Pages: 33 - 41
[F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma Hossein JadvarVicki QuanPeter S. Conti Original Article 29 February 2008 Pages: 42 - 47
Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy Kiyoshi NakamatsuMinoru SuzukiFumiharu Akai Original Article 29 February 2008 Pages: 48 - 53
Comparisons of the impact of systematic uncertainties in patient setup and prostate motion on doses to the target among different plans for definitive external-beam radiotherapy for prostate cancer SuYu ZhuTakashi MizowakiMasahiro Hiraoka Original Article 29 February 2008 Pages: 54 - 61
A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer Howard D. HomesleyNathan P. MeltzerAl A. Elbendary Original Article 29 February 2008 Pages: 62 - 65
Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer Magnus RizellMats AnderssonPer Lindnér Original Article 29 February 2008 Pages: 66 - 70
Retroperitoneal mature teratoma after orchidectomy for a stage IB pure embryonal testicular carcinoma Aart BeekerEpie BovenCees J. van Groeningen Case Report 29 February 2008 Pages: 71 - 73
Complete response of a pancreatic adenosquamous carcinoma to chemoradiotherapy Kotaro ShibagakiKoichi FujitaYoshikazu Kinoshita Case Report 29 February 2008 Pages: 74 - 77
A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene Naohiro IzawaSeiichi MatsumotoNoriyoshi Kawaguchi Case Report 29 February 2008 Pages: 78 - 82
Growing teratoma syndrome of ovary Roopa HariprasadLalit KumarMalini Vijayaraghavan Case Report 29 February 2008 Pages: 83 - 87
